Items where authors include "Swain, J"
Article
McNamara, MG, Swain, J, Craig, Z et al. (21 more authors) (2023) NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma. eClinicalMedicine, 60. 102015. ISSN 2589-5370
Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Gregory, W et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045
Zhong, J orcid.org/0000-0001-5325-3739, Palkhi, E, Buckley, DL orcid.org/0000-0001-6659-8365 et al. (7 more authors) (2021) Feasibility Study on Using Dynamic Contrast Enhanced MRI to Assess the Effect of Tyrosine Kinase Inhibitor Therapy within the STAR Trial of Metastatic Renal Cell Cancer. Diagnostics, 11 (7). 1302. ISSN 2075-4418
Craig, Z orcid.org/0000-0001-9930-6648, Swain, J, Batman, E et al. (16 more authors) (2020) NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC). BMJ Open, 10 (2). e034527. ISSN 2044-6055
Walsh, JS, Marshall, H orcid.org/0000-0003-0944-0152, Smith, IL et al. (9 more authors) (2019) Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial. PLOS Medicine, 16 (11). e1002960. ISSN 1549-1277
Albert, A, Andre, M, Anghinolfi, M et al. (1942 more authors) (2017) Search for High-energy Neutrinos from Binary Neutron Star Merger GW170817 with ANTARES, IceCube, and the Pierre Auger Observatory. Astrophysical Journal Letters, 850 (2). L35. ISSN 2041-8205
Abbott, BP, Abbott, R, Abbott, TD et al. (3611 more authors) (2017) Multi-messenger Observations of a Binary Neutron Star Merger. Astrophysical Journal Letters , 848 (2). L12. ISSN 2041-8205
Heyman, B, Swain, J, Gillman, M et al. (2 more authors) (1997) Alone in the crowd: How adults with learning difficulties cope with social networks problems. Social Science & Medicine, 44 (1). pp. 41-53. ISSN 0277-9536
Conference or Workshop Item
Swain, J, Smith, I, Smith, A et al. (3 more authors) (2015) TRYMS: The ethical and practical considerations of a double-blind placebo controlled randomised clinical trial. In: 3rd International Clinical Trials Methodology Conference, 16-17 Nov 2015, Glasgow, UK. (Unpublished)
Smith, I, Swain, J, Marshall, HC et al. (4 more authors) (2015) Testosterone Replacement in Young Male cancer Survivors (TRYMS) – pragmatic adaptation of trial design for a trial struggling with recruitment. In: 3rd International Clinical Trials Methodology Conference, 16-17 Nov 2015, Glasgow. (Unpublished)
Proceedings Paper
Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Ralph, C et al. (17 more authors) (2021) STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC). In: Annals of Oncology. ESMO Congress 2021, 16-21 Sep 2021, Paris, France. Elsevier , S1303-S1304.
McNamara, MG, Swain, J, Craig, Z et al. (11 more authors) (2019) NET-02: A multi-center, randomised, phase II trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients (pts) with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC). In: Journal of Clinical Oncology. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 31 May - 04 Jun 2019, Chicago, IL, USA. American Society of Clinical Oncology .